- Snow Shoveling, Slips on Ice Bring Cold Weather Dangers
- How Moving the Homeless to Hotels During the Pandemic Helps Everyone
- With 3 COVID Vaccines Approved, Is There a ‘Best’ Shot?
- It’s Too Soon to Lift COVID Restrictions: Fauci
- Health Highlights: March 5, 2021
- AHA News: Why Did Yankees Manager Get a Pacemaker, and How Does It Work?
- When Facebook, Twitter Flag Posts as ‘Unverified,’ Readers Listen
- Lockdowns Tied to Temporary Drops in Illicit Drug Seizures
- Formaldehyde in Hair Straighteners Prompts FDA Warning
- Big Paychecks Pay Off in Self-Confidence, Study Finds
Clinical Trials Update: Aug. 10, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Multiple Sclerosis
This study is evaluating an investigational product designed to enhance the central nervous system of adults with diagnosed relapsing, remitting or secondary progressive MS. To qualify, you must be aged 18 to 60 and attend eight overnight stays over a 22-week period.
The research site is in Phoenix, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/multiple_sclerosis.aspx.
—–
Hepatitis C
This study of an investigational drug is for people who have been treated unsatisfactorily for hepatitis C.
The research site is in La Mesa, Calif.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/hepatitis.aspx.
—–
Systemic Lupus Erythematosus (SLE)
This study is for people diagnosed with systemic lupus erythematosus, specifically with high anti-dsDNA and anti-RNP.
The research site is in Everett, Wash.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/lupus.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
